Start of work within the framework of a public-private partnership to create a federal network of nuclear medicine centers under the brand name "PET-Technology".
The nuclear medicine center was opened in Ufa in May. Regular deliveries of the 18F-FDG radiopharmaceutical for PET diagnostics began.
The production site in Yelets was opened in April. The site began supplying diagnostic centers of the Central Federal District with 18F-FDG radiopharmaceuticals.
Deliveries of radiopharmaceuticals to diagnostic centers in Belgorod began from the production site in Yelets, and to Yekaterinburg from the production site in Ufa.
Deliveries of radiopharmaceuticals to Samara began from the production site in Ufa.
The company changed its main development vector from medical to productive.
The company received a new name, leaving the PET-Technology brand to its medical partner.
The production site in Balashikha was included in the list of partner sites of the RadioMedSynthesis group. The site supplies radiopharmaceuticals to diagnostic centers in the Central Federal District.
Ufa began supplying radiopharmaceuticals to the Perm diagnostic center.
The list of partner sites of the RadioMedSynthesis group included the oncology dispensary in Kazan - the Republican clinical oncology dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal. Thanks to this, it was possible to reduce significantly the cost of radiopharmaceuticals delivery to Kirov, Perm and Izhevsk.
RadioMedSynthesis successfully delivered radiopharmaceuticals from the production site in Balashikha to the Novokuznetsk diagnostic center over a distance of more than 3,000 km, which is an absolute record for suppling of such radiopharmaceuticals.
Also, deliveries have been organized to diagnostic centers in Vladimir, Obninsk, Ivanovo from the Balashikha production site, and to the diagnostic center in Grozny from the site in Stavropol.
The production site in Stavropol became part of the RadioMedSynthesis group. The site supplies radiopharmaceuticals to diagnostic centers in Krasnodar, Rostov-on-Don, Astrakhan, Vladikavkaz, Grozny.
RadioMedSynthesis provides consulting services to the production site in Chelyabinsk. Radiopharmaceuticals are delivered to diagnostic centers in Yekaterinburg and Sterlitamak from Chelyabinsk.
Deliveries to the Bryansk diagnostic center have begun from the site in Yelets.
The production site in Novosibirsk began producing radiopharmaceuticals in December and supplying diagnostic centers in Omsk and Novokuznetsk.
The production site in the village of Pavlovskaya, Krasnodar Krai, began its work in May. The site supplies radiopharmaceuticals to diagnostic centers in Krasnodar and Rostov-on-Don.
The production site in Yelets has begun supplying radiopharmaceuticals to Saratov. The site in Novosibirsk has begun supplying radiopharmaceuticals to the diagnostic center opened in the same building. The production facility in Stavropol has begun supplying to the diagnostic center in Makhachkala.
Today, RadioMedSynthesis specializes in the production of radiopharmaceuticals, development and optimization of supply chains to diagnostic centers throughout Russia, and launch of new, more effective radiopharmaceuticals on the market.
